BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12661558)

  • 1. [German Cancer Society e.V. S3 guideline for PSA determination in diagnosis of prostatic carcinoma].
    Rübben H; Schalkhäuser K; Wolff J; Luboldt HJ;
    Onkologie; 2003 Feb; 26(1):88-9. PubMed ID: 12661558
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical usefulness of free PSA fraction as an indicator of prostate cancer.
    Filella X; Alcover J; Molina R; Giménez N; Rodríguez A; Jo J; Carretero P; Ballesta AM
    Int J Cancer; 1995 Dec; 63(6):780-4. PubMed ID: 8847133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PSA--monitoring the prostate. Diagnostic series: Early detection of prostatic carcinoma].
    Janssen K
    MMW Fortschr Med; 2000 Oct; 142(41):45. PubMed ID: 11085077
    [No Abstract]   [Full Text] [Related]  

  • 4. [Detection of prostate cancer. German guideline recommends opportunist screening].
    Arnheim K
    MMW Fortschr Med; 2010 Sep; 152(39):12-3. PubMed ID: 21058430
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy.
    Boyle P
    Ann Oncol; 1998 Dec; 9(12):1263-4. PubMed ID: 9932152
    [No Abstract]   [Full Text] [Related]  

  • 6. Early management of prostate cancer: how to respond to an elevated PSA?
    Canto EI; Slawin KM
    Annu Rev Med; 2002; 53():355-68. PubMed ID: 11818479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSA screening for prostate cancer: the current controversy.
    de Koning HJ; Schröder FH
    Ann Oncol; 1998 Dec; 9(12):1293-6. PubMed ID: 9932158
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostatic specific antigen (PSA).
    Alberti C
    Minerva Urol Nefrol; 1993 Jun; 45(2):83-4. PubMed ID: 7694380
    [No Abstract]   [Full Text] [Related]  

  • 9. PSA and prostate cancer diagnosis.
    Savage P; Waxman J
    Eur J Cancer; 1996 Jun; 32A(7):1097-9. PubMed ID: 8758236
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostate carcinoma].
    Schlemmer HP
    Radiologe; 2008 Jan; 48(1):45-51. PubMed ID: 17909738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological markers of prostate cancer].
    Seitz C; Djavan B
    Ann Urol (Paris); 2006 Dec; 40(6):329-35. PubMed ID: 17214230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How to use PSA in 2009].
    Ponholzer A; Stoiber F; Loidl W; Rauchenwald M; Schramek P; Madersbacher S
    Wien Med Wochenschr; 2009; 159(21-22):515-20. PubMed ID: 19997836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for prostate cancer.
    Neal DE; Donovan JL
    Ann Oncol; 1998 Dec; 9(12):1289-92. PubMed ID: 9932157
    [No Abstract]   [Full Text] [Related]  

  • 14. [PSA 2010--the beginning of a new era in early detection of prostate cancer].
    Börgermann C; Sieverding M; Fornara P; Graefen M; Hammerer P; Semjonow A; Schröder F; Rübben H
    Urologe A; 2006 Sep; 45 Suppl 4():127-33. PubMed ID: 16941115
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
    Lynch MJ
    J Urol; 2005 Sep; 174(3):1155; author reply 1155-6. PubMed ID: 16094096
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
    Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PSA-screening: sensible or meaningless?].
    Dubben HH
    Urologe A; 2009 Sep; 48(9):1103; author reply 1103-4. PubMed ID: 19727645
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
    Hoeltl W; Müller MM; Lunglmayr G
    J Urol; 2005 Jun; 173(6):2205; author reply 2205-6. PubMed ID: 15879895
    [No Abstract]   [Full Text] [Related]  

  • 19. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 20. [New challenges and earlier approved methods in the laboratory diagnosis of prostate cancer].
    Kovács GL
    Magy Onkol; 2014 Dec; 58(4):301-9. PubMed ID: 25517448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.